Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

Mise à jour : Il y a 4 ans
Référence : NCT00913120

Femme et Homme

Extrait

The purpose of this study is to examine the superiority of YM150 to the placebo and to evaluate the dose-dependent response of YM150 in patients undergoing elective total hip replacement surgery.


Critère d'inclusion

  • Venous Thromboembolism


Liens